Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer

Clinical trial NCT00453323 · UNKNOWN

Trial details

NCT number: NCT00453323
Sponsor: National Cancer Center, Korea
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2006-06-01
Primary completion: 2009-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.